Nasal Cancer Trends: What You Need to Know About Declining Risks & Rising Concerns
"A long-term study in the Netherlands reveals how occupational safety and smoking habits are reshaping the landscape of sinonasal cancers, especially among women."
Sinonasal cancers, rare tumors located in the nasal cavity and sinuses, present unique challenges in epidemiology and treatment. Given their rarity (incidence <1 per 100,000 people), understanding the trends in occurrence, mortality, and treatment is crucial.
Of particular interest is adenocarcinoma, a type of sinonasal cancer strongly linked to long-term exposure to wood or leather dust. Recognizing this connection, industries have implemented preventive measures, yet the impact of these changes, along with other factors, on cancer incidence remains an area of ongoing research.
This article will explore the long-term trends of sinonasal cancer in The Netherlands, focusing on adenocarcinoma and examining how factors like occupational exposure and smoking habits are influencing the changing patterns of this rare disease. Understanding these trends is crucial for informing prevention efforts and improving outcomes.
Rarity and Survival in Sinonasal Cancer
Sinonasal cancers are rare: one study describes them as 2–15 cases per million and 3.4% of head and neck tumors. Malignant tumors of the sinonasal cavity account for about 1% of all malignancies and 3% of head and neck malignancies; sinonasal adenocarcinoma (SNAC) makes up approximately 13% of sinonasal malignancies and is the second most common type after squamous cell carcinoma. A 2026 report gives a pooled five-year survival rate of 55% and notes that symptoms such as nasal obstruction, nosebleeds, nasal discharge, and facial swelling can be nonspecific.
A Diverse Group of Tumors
Sinonasal tumors comprise diverse benign and malignant lesions arising from epithelial, bone or cartilage, glandular, lymphoid, connective, and specialized neuronal tissues. Their natural history varies with anatomic site, histologic type, and tumor stage. A historical series of 386 patients treated from 1975 to 1995 found squamous cell carcinoma to be the most frequent histologic type, but it accounted for only about one-third of the nasal and paranasal sinus tumors.
Declining Risks for Men, Rising Concerns for Women: Key Findings
A comprehensive study in the Netherlands, tracking 4345 patients from 1989 to 2014, reveals significant shifts in the landscape of sinonasal cancer:
- Decreasing Incidence in Men: The incidence of sinonasal cancer in men has decreased to 11.5 per 1,000,000, primarily due to a decline in both SCC and adenocarcinoma cases. Specifically, adenocarcinoma saw a significant decrease (EAPC -4.3%).
- Increasing Incidence in Women: Conversely, the incidence in women has risen to 7 per 1,000,000 (EAPC +2.0%), largely driven by an increase in SCC. Adenocarcinoma incidence in women remained stable.
- Nasal Cavity Tumors on the Rise in Women: Tumors located in the nasal cavity significantly increased in women (EAPC +3.3%).
Recent Findings on Incidence and Outcomes
A population-based study of head and neck epithelial cancers in northeastern Spain examined incidence trends from 1994 to 2018. It reported declining incidence across head and neck cancers overall, with an annual percentage change (APC) of −1.83, and declines for several named sites, including the nasopharynx (APC −2.01). A separate 13-year analysis found that sinonasal cancer manifested mostly in the nasal cavity, where five-year overall survival was 63%.
Challenges in Classification and Treatment
Sinonasal malignancies are staged using the American Joint Committee on Cancer tumor/node/metastasis system, but T staging differs by location, with separate classifications for the maxillary sinus and the nasal cavity/ethmoid sinus. A 2023 review notes that generalized management approaches and guidelines tend to focus on the most common sinonasal cancers, which may not reflect the full range of these tumors. A 2026 meta-analysis of 13 studies involving 749 patients examined treatment failure patterns in sinonasal squamous cell carcinoma, including local recurrence, nodal recurrence, and distant metastasis; the available source excerpt does not provide the pooled rates.
Evidence Gaps in Comparing Treatments
Sinonasal malignancies are rare and heterogeneous, and the source review describes a paucity of robust data to guide management decisions. Using the National Cancer Data Base, its authors set out to characterize presenting features and compare outcomes by treatment modality. The provided source excerpt describes the study’s purpose but does not report comparative outcome results.
Implications and Future Directions
The study underscores the evolving nature of sinonasal cancer and highlights the impact of both occupational and lifestyle factors. The decrease in male adenocarcinoma suggests that workplace safety measures are indeed effective, while the rise in female SCC emphasizes the need for targeted interventions related to smoking.
Systemic Care Has Limited Evidence
Sinonasal malignant tumors include many histologic types with variable biological behavior, complicating care across the group. A 2026 retrospective multicenter study examined systemic treatment in France for 83 patients with recurrent or metastatic sinonasal carcinomas who were ineligible for curative treatment; it included patients treated between 2012 and 2021 and excluded squamous cell carcinoma. The study’s stated context is that advanced disease presents a therapeutic challenge because evidence on appropriate systemic management is limited.
Symptoms, Delayed Care, and Treatment Research
A 2024 case report describes a 64-year-old man who presented with nasal congestion and blood in his nasal discharge after more than 10 years of symptoms; the report says he had not sought medical attention after symptoms began. Separately, the phase II SINTART 1 study found that histology-driven induction chemotherapy followed by chemoradiotherapy in responsive patients with advanced sinonasal cancer was feasible. Its findings suggest a possible role for induction chemotherapy in newly diagnosed, resectable tumors, especially sinonasal undifferentiated carcinoma (SNUC), to help select patients with favorable prognosis.
As the researchers note, the increasing incidence of female nasal cavity tumors may also be linked to changing smoking habits in the Netherlands, with fewer male and more female smokers. Further research is needed to fully understand these relationships.
Looking ahead, continued monitoring of sinonasal cancer trends, along with further investigation into the role of smoking and other risk factors, is crucial for optimizing prevention strategies and improving outcomes for both men and women. Given the complexity of these cancers, the centralization of care remains a key consideration.